427 related articles for article (PubMed ID: 19873759)
1. [Suppression of the antigen-specific T cell immune response by co-immunization with the HBV DNA vaccine and recombinant HBsAg].
Du X; Wang J; Kang Y; Xiao W; Zhao G; Wang B
Wei Sheng Wu Xue Bao; 2009 Jul; 49(7):938-42. PubMed ID: 19873759
[TBL] [Abstract][Full Text] [Related]
2. [Adjuvant effect of plasmid vector-expressed OX40L on candidate DNA vaccine against type B heptatitis].
Du X; Kang Y; Wang X; Wang J; Zhao G; Wang B
Wei Sheng Wu Xue Bao; 2009 Mar; 49(3):357-62. PubMed ID: 19623960
[TBL] [Abstract][Full Text] [Related]
3. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination.
Du X; Zheng G; Jin H; Kang Y; Wang J; Xiao C; Zhang S; Zhao L; Chen A; Wang B
J Gene Med; 2007 Feb; 9(2):136-46. PubMed ID: 17310492
[TBL] [Abstract][Full Text] [Related]
4. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
[TBL] [Abstract][Full Text] [Related]
5. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
Li L; Tian YJ; Shen H; Zhao XP; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):275-9. PubMed ID: 19403026
[TBL] [Abstract][Full Text] [Related]
6. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
7. [Reciprocal priming-boosting role of HBsAg and DNA vaccines].
Zhou Z; Chen WS; Zhang HH; Yao JL
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):212-4. PubMed ID: 12716517
[TBL] [Abstract][Full Text] [Related]
8. Immune response induced by a different combined immunization of HBsAg vaccine.
Wu T; Chen M; Ou SH; Cheng T; Zhang J; Xia NS
Intervirology; 2007; 50(5):336-40. PubMed ID: 17700028
[TBL] [Abstract][Full Text] [Related]
9. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
Li X; Yang X; Li L; Liu H; Liu J
Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
[TBL] [Abstract][Full Text] [Related]
10. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.
Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W
Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297
[TBL] [Abstract][Full Text] [Related]
11. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
12. Cationic polymers that enhance the performance of HbsAg DNA in vivo.
Bos GW; Kanellos T; Crommelin DJ; Hennink WE; Howard CR
Vaccine; 2004 Dec; 23(4):460-9. PubMed ID: 15530694
[TBL] [Abstract][Full Text] [Related]
13. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
[TBL] [Abstract][Full Text] [Related]
14. Cationic transfersomes based topical genetic vaccine against hepatitis B.
Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
Zhou C; Peng G; Jin X; Tang J; Chen Z
Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of low doses of plant-based HBsAg induced antigen-specific IgAs and IgGs in mice, without increasing levels of regulatory T cells.
Kostrzak A; Cervantes Gonzalez M; Guetard D; Nagaraju DB; Wain-Hobson S; Tepfer D; Pniewski T; Sala M
Vaccine; 2009 Jul; 27(35):4798-807. PubMed ID: 19539581
[TBL] [Abstract][Full Text] [Related]
17. [Immunogenicity of a multiple epitope DNA vaccine against hepatitis B virus].
Luo LM; Li M; Xia H; Chen BH; Wang P; Hao WB
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):517-21. PubMed ID: 15367337
[TBL] [Abstract][Full Text] [Related]
18. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen.
Song ES; Park SA; Kim SH; Cho YJ; Ahn BY; Ahn BC; Lee NG
FEMS Immunol Med Microbiol; 2007 Dec; 51(3):496-504. PubMed ID: 17877731
[TBL] [Abstract][Full Text] [Related]
20. [The study about immune response to Balb/c mice inoculated with hepatitis B virus DNA vaccine pCI/S2S].
He X; Zhao LS; Zhou TY; He F; Jiang N
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):945-8. PubMed ID: 18095592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
